Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-15

FDA Approved: CLOBAZAM — Original Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approves CLOBAZAM as an original ANDA for a generic clobazam product from Taro Pharmaceuticals U.S.A., Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBAZAM (CLOBAZAM)

Snippet

ORIG AP for CLOBAZAM (CLOBAZAM)